¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2023 Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-04-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2023 Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-04-29
±³À°ÀÏÀÚ : 2023-04-29
±³À°Àå¼Ò : ´õÄÉÀÌÈ£ÅÚ¼­¿ï °Å¹®°íȦ

±³À°ÁÖÁ¦ : ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2023 Ãá°èÇмú´ëȸ(1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑÆÄŲ½¼º´¹×ÀÌ»ó¿îµ¿ÁúȯÇÐȸ
´ã´çÀÚ : Ãֹ̼Ò
¿¬¶ôó : 02-6395-2876  

À̸ÞÀÏ : movement@kmds.or.kr

±³À°Á¾·ù : ½Å°æ°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 25ºÐ

¼¼ºÎ¼ö°­·á : 160,000¿ø  

ºñ°í »çÀüµî·Ï : 80,000¿ø / ÁØȸ¿ø 50,000¿ø / ºñȸ¿ø Àü¹®ÀÇ 160,000¿ø / ºñȸ¿ø Àü°øÀÇ 60,000¿ø ÇöÀåµî·Ï : Çмú´ëȸ : Á¤È¸¿ø 100,000¿ø / ÁØȸ¿ø 60,000¿ø / ºñȸ¿ø Àü¹®ÀÇ 200,000¿ø / ºñȸ¿ø Àü°øÀÇ 70,000¿ø

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 09:00~09:35 Treatment Based on Semiology or on Genetics or Both? : Focus on Dystonia Marie Vidailhet(Hôpital de la Pitié-Salpêtrière Paris France)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 09:35~10:10 Surgical Treatment for Movement Disorders Alfonso Fasano(University of Toronto Canada)

Åä·Ð 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 10:10~10:15 Q&A ¹éÁ¾»ï(ÀÎÁ¦ÀÇ´ë)

ÈÞ½Ä 04¿ù 29ÀÏ 10:15~10:25 ÈÞ½Ä ( )

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 10:25~10:55 Mechanism and Application of Immunologic Treatment for Movement Disorders À̼øÅÂ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 10:55~11:25 Updates in Rehabilitation for Parkinson Àå¿øÇõ(¼º±Õ°üÀÇ´ë ÀçÈ°ÀÇÇаú)

Åä·Ð 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 11:25~11:30 Q&A Á¶Áøȯ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 11:30~12:10 Genetic Landscape of Parkinson''s Disease ±èÀ±Áß(¿¬¼¼ÀÇ´ë)

½Ä»ç 04¿ù 29ÀÏ 12:10~13:05 ½Ä»ç ( )

Åä·Ð 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 13:05~14:00 Poster Session : Guided Poster Tour ±è¿µÀº ¿ÀÀÀ¼® Àå¿ì¿µ(ÇѸ²ÀÇ´ë Ãæ³²ÀÇ´ë ¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 14:00~14:30 Nigrosome 1, Neuromelanin, and Novel Imaging Analysis for Movement Disorders ±èÀÀ¿±(¼º±Õ°üÀÇ´ë ¿µ»óÀÇÇаú)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 14:30~15:00 Digital Biomarker for Movement Disorders ¹ÚÁø¼¼(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 15:00~15:30 Imaging and Laboratory Tests in the Diagnosis of MSA and DLB À¯ÇѼö(¿¬¼¼ÀÇ´ë)

ÈÞ½Ä 04¿ù 29ÀÏ 15:30~15:40 ÈÞ½Ä ( )

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 15:40~16:00 Drug Repurposing in Movement Disorder À̸íÁØ(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 16:00~16:20 Pathologic Alpha-synuclein Protein Targeting Antibody Immunotherapy ¾È¼º¿ø(ABL Bio)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 16:20~16:40 CBD Oil and Glutathione for PD: Do they Work? À±Áö¿µ(ÀÌÈ­ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2023 Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-04-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023 Á¦15Â÷ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­ ±³À° (»ó¹Ý±â) -2ÀÏÂ÷- : 2023-04-29
´ÙÀ½±Û ´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2023 (3ÀÏÂ÷) : 2023-04-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
1382 ¼­¿ï ±¸·Îº´¿ø È£½ºÇǽº Àü¹®Àη ǥÁر³À° : 2018-11-03 0 373 2018-10-11
1381 ´ë±¸ ´ë±¸°æºÏ°³¿ø³»°úÀÇ»çȸ Ãß°èÇмú´ëȸ : 2018-11-03 0 1,020 2018-10-11
1380 ÀÎõ ±æº´¿ø ÀÎõ±¤¿ª½ÃÀÇ»çȸ 2018 ÇϹݱ⠿¬¼ö±³À° : 2018-11-03 0 734 2018-10-11
1379 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ Àü°øÀÇ ¿¬¼ö°­Á : 2018-11-03 0 1,049 2018-10-11
1378 ¼­¿ï ¼öºÎ¿Ü°úÃÖ½ÅÇغÎÇÐ, ¼öºÎ¿Ü°úÃÖ½ÅÄ¡·áµ¿Çâ, ¼öºÎ¿Ü°úÀü¹®ÀDZ⺻Áö½Ä : 2018-11-03 0 730 2018-10-11
1377 ¼­¿ï ¼­¿ï´ë¾î¸°À̺´¿ø ´ëÇѼöºÎ¿Ü°úÇÐȸ Ãß°èÇмú´ëȸ : 2018-11-03 1 537 2018-10-11
1376 ¼­¿ï ´ëÇѾȰúÇÐȸ Á¦120ȸ Çмú´ëȸ (1ÀÏÂ÷) : 2018-11-02 0 3,559 2018-10-11
1375 ¼­¿ï ´ëÇѼҾÆû¼Ò³âÁ¤½ÅÀÇÇÐȸ 2018³âµµ Ãß°èÇмú´ëȸ : 2018-11-02 0 586 2018-10-11
1374 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ºÒ¾ÈÀå¾ÖÀÇ ÀÌÇØ¿Í Ä¡·áÀÇ ÃÖ½ÅÁö°ß : Cutting edge understanding and treatment of anxiety disorder : 2018-11-02 0 944 2018-10-11
1373 ¼­¿ï ±¸·Îº´¿ø È£½ºÇǽº Àü¹®Àη ǥÁر³À° : 2018-11-02 0 769 2018-10-11
1372 ¼­¿ï ½Ã¸³µ¿ºÎº´¿ø MUPS(Medically Unexplained Physical Symptoms(ÀÇÇÐÀûÀ¸·Î ¼³¸íµÇÁö ¾Ê´Â ½Åü Áõ»óµé) : 2018-11-02 0 523 2018-10-11
1371 °æºÏ 2018 °æ»óºÏµµ °øÁߺ¸°ÇÀÇ»ç Á÷¹«±³À° (2Â÷) : 2018-11-02 0 467 2018-10-11
1370 ¼­¿ï ¼­¿ï´ë¾î¸°À̺´¿ø ´ëÇѼöºÎ¿Ü°úÇÐȸ Ãß°èÇмú´ëȸ : 2018-11-02 0 460 2018-10-11
1369 ¼­¿ï Áß¾Ó´ëÇб³º´¿ø 2018³â ÀÇ»ý¸í¿¬±¸¿ø À¶ÇÕ¿¬±¸ ½ÉÆ÷Áö¾ö : 2018-11-01 0 783 2018-10-11
1368 ´ë±¸ °æºÏ´ëÇб³º´¿ø ´ëÇÑ¿µ»óÀÇÇÐȸ ´ë±¸°æºÏÁöȸ 11¿ù Áý´ãȸ : 2018-11-01 0 949 2018-10-11
1321 | 1322 | 1323 | 1324 | 1325 | 1326 | 1327 | 1328 | 1329 | 1330
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷